Navigation Links
Guys, take note: Male birth control pill may be ready soon, says Texas A&M professor
Date:9/5/2012

Attention men: The day may be coming soon when you can take your own birth control pill with no side effects, according to a study done by a group of scientists that includes a Texas A&M University researcher.

Qinglei Li, an assistant professor in Texas A&M's College of Veterinary Medicine & Biomedical Sciences, is part of a team of researchers led by Martin Matzuk at Baylor College of Medicine and James Bradner at Dana-Farber Cancer Institute who made the discovery, and their work is published in the journal Cell.

Working on mice, the team found that a compound called JQ1 acts as an inhibitor to sperm production and also sperm mobility.

"Both of these are needed for fertility, but JQ1 prevents both," Li says of the findings.

"It stopped the sperm production very dramatically. More good news is that there appear to be no side effects whatsoever. Once the JQ1 was no longer given to the mice, they were back to their normal reproduction rates, and it did not affect mating behavior or the health of the offspring."

Though the mice were given injections, the team believes that a pill could eventually be developed for the same results.

A male contraceptive pill has been talked about for decades, but so far none has been successfully created despite a strong demand.

While many men might be reluctant to take out the trash or ask for directions if they are lost, recent studies have shown that about 70 percent of men would be willing to take a birth control pill if it were available.

One drawback to many female contraceptives is that they sometimes interfere with hormones, especially estrogen. But Li says the team is confident that JQ1 does not affect testosterone levels in men, and appears to have no other side effects as well.

As with many discoveries, the JQ1 compound appears to have come about by accident.

It was originally used for anti-cancer treatments, but researchers found it was also an excellent compound in controlling fertility.

"This is an exciting step in male contraception," Li adds.

"A compound with more specificity will be needed before clinical trials can be done for humans. It does not mean a male birth control just yet, but it is a great step forward in that direction."


'/>"/>
Contact: Keith Randall
keith-randall@tamu.edu
979-845-4644
Texas A&M University
Source:Eurekalert

Related medicine news :

1. Multiple Abortions May Raise Risk of Preemie Birth Later
2. What babies eat after birth likely determines lifetime risk of obesity, rat study suggests
3. Cervical Disease Treatment Not Linked to Premature Birth Risk
4. Male Birth Control Drug Shows Promise in Mice
5. Strawberry birthmarks grow rapidly when babies just weeks old, Mayo Clinic finds
6. Vaginal Deliveries as Safe as C-Sections for Most Preterm Births
7. 1 in 3 post-partum women suffers PTSD symptoms after giving birth
8. Vaginal delivery as safe as cesarean for most early preterm births
9. Heart Defect at Birth Signals Need to Check for Other Disorders: AHA
10. Childbirth After 30 Lowers Risk of Endometrial Cancer: Study
11. Women who give birth after age 30 lower their risk of endometrial cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... ... Philpart, senior director at PolicyLink, will be the keynote speaker at its second ... and Men of Color Framework, which develops comprehensive strategies to create and expand ...
(Date:2/21/2017)... ... February 21, 2017 , ... Support of value-based care ... the secure exchange of data across industry solutions, Fogo Data Centers announces the launch ... community. A healthy community is one in which all systems work well, work ...
(Date:2/21/2017)... ... February 21, 2017 , ... HIMSS is ... connected care demonstration spanned multiple health information systems including OpenEMR, EMRDirect, and ... providers have no Health Information Exchange outside of faxing. Medal’s innovative technology “meets ...
(Date:2/20/2017)... ... February 20, 2017 , ... A new digital ... are called back for additional examinations without sacrificing cancer detection, according to a ... the U.S. Food and Drug Administration approved digital breast tomosynthesis (DBT) for use ...
(Date:2/20/2017)... ... February 20, 2017 , ... Scrubbing in for his first ... Dr. Christopher Pezzi remembers the excitement of the surgeon training him. , “He was ... to do this? Don’t tell anyone, but I would do it for free,’” Dr. ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... Feb. 21, 2017  International Isotopes Inc. (OTCQB: INIS) ... placement with certain investors for approximately $3.4 million of ... Series C Convertible Redeemable Preferred Stock (the "Series C ... annual rate of 6% and is convertible into common ... use the proceeds for operating capital, to pay off ...
(Date:2/21/2017)... , Feb. 21, 2017 Research and Markets ... Devices - Global Strategic Business Report" report to their offering. ... The report provides separate comprehensive ... , Europe , Asia-Pacific , ... and forecasts are provided for the period 2015 through 2022. Also, a ...
(Date:2/21/2017)... 21, 2017 Research and Markets has announced the ... 2016" report to their offering. ... The latest research Uterine cancer Drugs Price Analysis and Strategies ... cancer market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Uterine cancer ...
Breaking Medicine Technology: